JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
CLSD
6076
DELISTED
Clearside Biomedical
CLSD
| $3K | ﹤0.01% |
208
-717
| -78% | -$13.9K |
2017 Q4
21 quarters
|
|
6077
CytomX Therapeutics
CTMX
$547M
| $3K | ﹤0.01% |
1,730
| – | – |
2016 Q4
25 quarters
|
|
6078
State Street SPDR MSCI Emerging Markets Fossil Fuel Reserves Free ETF
EEMX
$187M
| $3K | ﹤0.01% |
+100
| New | +$3.03K |
2023 Q1
0 quarters
|
|
6079
Genelux
GNLX
$115M
| $3K | ﹤0.01% |
+100
| New | +$1.62K |
2023 Q1
0 quarters
|
|
6080
Northern Trust Global Quality Real Estate ETF
GQRE
$439M
| $3K | ﹤0.01% |
+66
| New | +$3.6K |
2023 Q1
0 quarters
|
|
6081
iShares Gold Trust Micro
IAUM
$6.55B
| $3K | ﹤0.01% |
+146
| New | +$2.76K |
2023 Q1
0 quarters
|
|
|
IGI
6082
Western Asset Investment Grade Defined Opportunity Trust
IGI
$95.1M
| $3K | ﹤0.01% |
+159
| New | +$2.67K |
2023 Q1
0 quarters
|
|
|
IMA
6083
ImageneBio Inc
IMA
$52.2M
| $3K | ﹤0.01% |
73
| – | – |
2021 Q2
7 quarters
|
|
|
CD
6084
Chaince Digital Holdings
CD
$735M
| $3K | ﹤0.01% |
+1,792
| New | +$1.99K |
2023 Q1
0 quarters
|
|
6085
Monopar Therapeutics
MNPR
$518M
| $3K | ﹤0.01% |
+483
| New | +$7.15K |
2023 Q1
0 quarters
|
|
6086
CALL
MP Materials
MP
$8.3B
| $3K | ﹤0.01% |
100
-203,400
| -100% | -$6.15M |
2021 Q3
6 quarters
|
|
6087
BlackRock MuniYield Pennsylvania Quality Fund
MPA
$126M
| $3K | ﹤0.01% |
264
-3,986
| -94% | -$45.6K |
2022 Q4
1 quarter
|
|
|
MRUS
6088
DELISTED
Merus
MRUS
| $3K | ﹤0.01% |
161
| – | – |
2020 Q4
9 quarters
|
|
6089
Nuveen California Quality Municipal Income Fund
NAC
$1.57B
| $3K | ﹤0.01% |
+256
| New | +$2.85K |
2023 Q1
0 quarters
|
|
|
NOAH
6090
Noah Holdings
NOAH
$535M
| $3K | ﹤0.01% |
198
-26,008
| -99% | -$482K |
2016 Q3
26 quarters
|
|
|
NQP
6091
DELISTED
Nuveen Pennsylvania Quality Municipal Income Fund
NQP
| $3K | ﹤0.01% |
288
-629
| -69% | -$7.19K |
2022 Q4
1 quarter
|
|
6092
Nuveen Select Tax-Free Income Portfolio
NXP
$829M
| $3K | ﹤0.01% |
+184
| New | +$2.65K |
2023 Q1
0 quarters
|
|
6093
Paysign
PAYS
$806M
| $3K | ﹤0.01% |
1,006
+877
| +680% | +$3K |
2019 Q1
16 quarters
|
|
6094
Puma Biotechnology
PBYI
$485M
| $3K | ﹤0.01% |
1,103
| – | – |
2013 Q2
39 quarters
|
|
|
PDT
6095
John Hancock Premium Dividend Fund
PDT
$572M
| $3K | ﹤0.01% |
+232
| New | +$2.99K |
2023 Q1
0 quarters
|
|
6096
Pixelworks
PXLW
$41.3M
| $3K | ﹤0.01% |
+187
| New | +$3.94K |
2023 Q1
0 quarters
|
|
6097
Saratoga Investment
SAR
$266M
| $3K | ﹤0.01% |
+100
| New | +$2.64K |
2023 Q1
0 quarters
|
|
6098
ProShares UltraShort Russell2000
TWM
$65.5M
| $3K | ﹤0.01% |
42
+27
| +180% | +$2.01K |
2022 Q2
3 quarters
|
|
6099
CALL
Unity
U
$20B
| $3K | ﹤0.01% |
+100
| New | +$3.22K |
2023 Q1
0 quarters
|
|
|
UBFO
6100
DELISTED
United Security Bancshares
UBFO
| $3K | ﹤0.01% |
504
+411
| +442% | +$3.06K |
2017 Q4
21 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.